Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,989-3,000 of 10,612

Drug study icon

CompletedNCT05117632

ALTO-100 in MDD and/or PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionDrugFrom 18 Years to 69 Years

Countries: United States
Sponsor: Alto Neuroscience
Condition: PTSD, Depression

Behavioral study icon

WithdrawnNCT03582150

Ambulatory Alcohol Detoxification With Remote Monitoring

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AddictionBehavioralFrom 21 Years to 75 Years

Countries: United States
Sponsor: Stanford University
Condition: Addiction

Behavioral study icon

CompletedNCT03049904

American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Washington
Condition: Addiction

Behavioral study icon

TerminatedNCT01733680

Amiloride Hydrochloride as an Effective Treatment for ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: State University of New York - Upstate Medical University
Condition: ADHD

Behavioral study icon

CompletedNCT00343928

Amino Acids, Serotonin, and Body Weight Regulation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralFrom 18 Years to 40 Years

Countries: United States
Sponsor: Beth Israel Deaconess Medical Center
Condition: Eating disorders

Drug study icon

CompletedNCT00001658

Amoxicillin for Pediatric Autoimmune Disorders Associated With Streptococcal Infections

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: OCD

Other study type icon

Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 12 Years to 30 Years

Countries: United States, Australia, Canada, ...
Sponsor: Brigham and Women's Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT04027361

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 25 Years

Countries: United States
Sponsor: Tris Pharma, Inc.
Condition: ADHD

Drug study icon

CompletedNCT03834766

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Tris Pharma, Inc.
Condition: ADHD

Behavioral study icon

SuspendedNCT04934553

Amplification of Positivity for Addiction Co-Occurring With Anxiety or Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, Addiction, ...BehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Charles Taylor
Condition: Depression, Addiction, ...

Behavioral study icon

CompletedNCT04945239

Amplification of Positivity to Enhance Social Connections in Anxiety and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Depression, Anxiety

Drug study icon

CompletedNCT03055338

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Merck Sharp & Dohme LLC
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.